Clinical trials
Not yet recruiting Melanoma trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2024 | 1 |
| 2026 | 17 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Not yet recruiting | 19 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 2 |
| University of Southern California | 2 |
| Abramson Cancer Center at Penn Medicine | 1 |
| City of Hope Medical Center | 1 |
| Indiana University | 1 |
| National Cancer Institute (NCI) | 1 |
| OHSU Knight Cancer Institute | 1 |
| Power Life Sciences Inc. | 1 |
| Rapa Therapeutics LLC | 1 |
| Scancell Ltd | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Melanoma | 19 |
| Adenocarcinoma, Follicular | 1 |
| Basal Cell Carcinoma | 1 |
| Carcinoma, Hepatocellular | 1 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Carcinoma, Squamous Cell | 1 |
| Chordoma | 1 |
| Congenital Bone Marrow Failure Syndromes | 1 |
| Costello Syndrome | 1 |
| Fanconi Anemia | 1 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.